Skip to main content

Court strikes down federal rule that sharply increased prescription costs for many patients

By MarketWatch / Dow Jones  
   October 03, 2023

Several patient-advocacy groups last year sued the federal government in an effort to overturn the rule, arguing that it conflicts with the ACA and provides a windfall to insurers.

Full story


Get the latest on healthcare leadership in your inbox.